REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,235,200 | +89.5% | 120,000 | +69.0% | 1.52% | +16.5% |
| Q1 2023 | $6,455,320 | +99.9% | 71,000 | -16.5% | 1.30% | +91.7% |
| Q4 2022 | $3,229,150 | +1.8% | 85,000 | -18.6% | 0.68% | +4.0% |
| Q2 2022 | $3,172,000 | +176.5% | 104,369 | +198.2% | 0.65% | +118.8% |
| Q1 2022 | $1,147,000 | -57.8% | 35,000 | -66.0% | 0.30% | -60.4% |
| Q4 2021 | $2,716,000 | -22.9% | 103,000 | +194.3% | 0.75% | -25.7% |
| Q3 2021 | $3,521,000 | -40.8% | 35,000 | -16.7% | 1.01% | -38.1% |
| Q2 2021 | $5,944,000 | +35.5% | 42,000 | -4.5% | 1.64% | +30.6% |
| Q1 2021 | $4,387,000 | -29.0% | 44,000 | -12.0% | 1.25% | -31.8% |
| Q4 2020 | $6,181,000 | +58.6% | 50,000 | +25.0% | 1.84% | +54.2% |
| Q3 2020 | $3,897,000 | – | 40,000 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |